Sassi Nir
SEC CIK 1760673 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | CFO | 26.8K | — | — | 1 | 2025-12-22 | 2025-12-22 |
Most active insiders at INDP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ben-Tzvi Avraham | Dir | — | — |
| 2 | Newman Michael James | CSO, Dir | — | — |
| 3 | Sassi Nir | CFO | — | — |
| 4 | Linscott Walt Addison | COO | — | — |
| 5 | Meckler Jeffrey A | Co-CEO, Dir, 10% | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-12-22 | INDP | Indaptus Therapeutics, Inc. | Sassi Nir | CFO | A - Grant | $2.03 | +26.8K | 26.8K | New | +$54.3K |
Purchase Sale Sale after option exercise All abbreviations